Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Change in Cash: 2018-2024

Historic Change in Cash for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$55.0 million.

  • Arcturus Therapeutics Holdings' Change in Cash rose 30.43% to -$16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.8 million, marking a year-over-year increase of 24.23%. This contributed to the annual value of -$55.0 million for FY2024, which is 21.94% down from last year.
  • Arcturus Therapeutics Holdings' Change in Cash amounted to -$55.0 million in FY2024, which was down 21.94% from -$45.1 million recorded in FY2023.
  • Arcturus Therapeutics Holdings' 5-year Change in Cash high stood at $391.5 million for FY2020, and its period low was -$90.4 million during FY2021.
  • For the 3-year period, Arcturus Therapeutics Holdings' Change in Cash averaged around -$26.2 million, with its median value being -$45.1 million (2023).
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Change in Cash soared by 1,030.19% in 2020 and then crashed by 310.61% in 2023.
  • Yearly analysis of 5 years shows Arcturus Therapeutics Holdings' Change in Cash stood at $391.5 million in 2020, then slumped by 123.10% to -$90.4 million in 2021, then soared by 123.67% to $21.4 million in 2022, then crashed by 310.61% to -$45.1 million in 2023, then fell by 21.94% to -$55.0 million in 2024.